written on 12.06.2017

Switzerland Pharma Report

main_img

This report offers companies, investors, policymakers, and stakeholders crucial insight into the specificities of Swiss pharmaceuticals, biotech, and healthcare, based on in-depth interviews conducted with leaders and pioneers across the value chain, from government representatives, global affiliate heads, and founders of innovative local SMEs.

In spite of high operating costs and a sometimes-byzantine regulatory environment, major MNCs are flocking to establish regional headquarters in a country frequently ranked the most innovative in the world. Complementary thriving ecosystems of biotech startups, contract research and manufacturing organizations, as well as a whole host of niche service providers has also sprung up across Switzerland, many of which are featured in the report.

We use cookies to ensure that we give you the best experience on our site. For more info click here